--2024/Q4-- / 4.129B--
Nov 6, 20242024/Q3-- / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--
Jan 31, 20242023/Q44.457B / 4.010B--
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 18.640
- +0.190+1.03%
Close Nov 4 16:00 ET
- 18.570
- -0.070-0.38%
Pre 05:00 ET
21.12BMarket Cap-47794P/E (TTM)
18.800High18.380Low7.09MVolume18.530Open18.450Pre Close131.95MTurnover0.63%Turnover RatioLossP/E (Static)1.13BShares19.08052wk High3.32P/B20.99BFloat Cap8.55052wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM2.28%Amplitude3.107Historical Low18.604Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Teva Pharmaceutical Industries Q3 2024 Estimates Date
Currency：USDNov 6, 2024
| Estimate | YoY | |
| Revenue | 4.13B | +7.14% |
| EPS | -<0.01 | -103.57% |
Analyst Rating
Nov 1, 2024
Teva Pharmaceutical Industries Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Teva Pharmaceutical Industries Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
